Skip to main content
Premium Trial:

Request an Annual Quote

CORRECTED: Genometrix Unveils Bioinformatics Tool for Gene Expression Analysis

This story has been corrected from a previous version, which stated that VistaLogic would be sold separately from its other services.

NEW YORK, March 1 - Genometrix of The Woodlands, Texas said Thursday it had released VistaLogic Information System, a bioinformatics solution designed to help researchers analyze gene expression and genotyping data.

Genometrix said that VistaLogic would be made available along with its microarray services. The software will not be sold separately. 

The company, which recently withdrew its planned initial public offering due to poor market conditions, said that VistaLogic was designed to handle the large number of data points generated by high-throughput microarray-based genomic studies.

VistaLogic aims to help researchers assimilate data from multiple experiments, combine extensive sample information with array results, and analyzing both gene expression profiles and SNP frequencies within one application.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.